Company / AR per Share
United Therapeutics AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$7.81
FY2025
5-year range
$4.46 / $7.81
FY2021-FY2025
Trend
+31.6%
vs FY2024
Sector context
#10 of 113
Health Care
What the data says
Among 113 Health Care companies, United Therapeutics is in the top 9% for ar per share. AR per Share has fluctuated over the past 10 years, ranging from $3.47 in FY2019 to $7.81 in FY2025.
Based on SEC 10-K filings.
7.81 in FY2025 with a 5-year CAGR of +16.8%. Top quartile in the Health Care sector.
Improved from $6.06 to $7.81 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +16.9%
- 5-Year CAGR
- +16.8%
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 113This company $7.81 Sector average $28.83
▼
-72.9% below sector average
Key checks
Key Insights
- In FY2025, ar per share increased 31.6% year-over-year.
- Ranks #10 out of 113 companies in the Health Care sector.
- Lowest ar per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 6.00 (safe zone, above 2.9 threshold)
- Strong profit margin: 40.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.81 | +31.6% |
| FY2024 | $5.94 | -2.0% |
| FY2023 | $6.06 | +24.0% |
| FY2022 | $4.89 | +9.4% |
| FY2021 | $4.46 | +24.5% |
| FY2020 | $3.59 | +3.3% |
| FY2019 | $3.47 | -14.5% |
| FY2018 | $4.06 | -41.2% |
| FY2017 | $6.91 | +47.5% |
| FY2016 | $4.69 | +14.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026